Section Arrow
Quote
KVUE.NYSE
- Kenvue
Quotes are at least 15-min delayed:2024/11/15 22:03 EST
Last
 23.82
+0.21 (+0.89%)
Day High 
24.13 
Prev. Close
23.61 
1-M High
23.95 
Volume 
16.17M 
Bid
23.59
Ask
24.18
Day Low
23.44 
Open
23.52 
1-M Low
21.37 
Market Cap 
45.22B 
Currency USD 
P/E 41.42 
%Yield 3.38 
10-SMA 23.23 
20-SMA 22.99 
50-SMA 22.75 
52-W High 24.13 
52-W Low 17.67 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
0.57/1.22
Enterprise Value
53.00B
Balance Sheet
Book Value Per Share
5.31
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
15.44B
Operating Revenue Per Share
8.05
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health19.32-1.53-7.34%273PE
KVUEKenvue23.82+0.21+0.89%41.42PE
PGProcter & Gamble Company169.54+2.46+1.47%27.71PE
CLColgate-Palmolive Company93.56+2.11+2.31%26.66PE
COTYCOTY7.2-0.39-5.14%84.22PE
Quotes are at least 15-min delayed：2024/11/15 22:03 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space,including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.